Performance reporting through clear and timely information
Enabling better health care while creating a sustained and growing investment opportunity.
If you invest or are considering investing in TSO3, you will want to keep current with the Company’s performance and understand any fluctuations. TSO3’s online Investor Relations section keeps you up-to-date with the latest in financial reporting, including annual reports, quarterly results, and conference call webcasts. As an investment, TSO3 builds value in the health care market through rapid research prototyping. A leading innovator in low-temperature sterilization technology, TSO3 also partners with developers in creating next-generation medical devices to ensure sterilization for these devices will be viable.
|Investor News||Investor Events|
|March 21, 2017: TSO3 Reports Record Fourth Quarter and Full Year 2016 Results||March 21, 2017: Replay Webcast - TSO3 Reports Record Fourth Quarter and Full Year 2016 Results|
|March 07, 2017: TSO3 Sets Fourth Quarter and Full Year 2016 Earnings Call for Tuesday, March 21, 2017 at 10:30 a.m. EDT||March 12, 2017: TSO3 Sets Fourth Quarter and Full Year 2016 Earnings Call for Tuesday, March 21, 2017 at 10:30 a.m. EDT|
|February 16, 2017: TSO3 Appoints Dr. Linda Rosenstock and Mr. Jeffrey Pompeo to its Board of Directors|